King Pharmaceuticals KG Liability for Unpaid Claims and Claims Adjustment Expense, Net
Liability for Unpaid Claims and Claims Adjustment Expense, Net at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's liability for unpaid claims and claims adjustment expense, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's liability for unpaid claims and claims adjustment expense, net?
- King Pharmaceuticals (KG) reported liability for unpaid claims and claims adjustment expense, net of $156.97M in Q1 2026.